Envoy Medical, Inc.
COCH
$0.84
$0.045.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -46.15% | 69.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -46.15% | 69.57% | |||
| Cost of Revenue | -13.25% | 3.54% | |||
| Gross Profit | -3.21% | 13.33% | |||
| SG&A Expenses | 17.21% | 11.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.69% | -0.10% | |||
| Operating Income | -12.58% | 0.72% | |||
| Income Before Tax | -13.92% | -13.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.92% | -13.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.92% | -13.85% | |||
| EBIT | -12.58% | 0.72% | |||
| EBITDA | -12.98% | 1.21% | |||
| EPS Basic | -9.21% | -11.01% | |||
| Normalized Basic EPS | -11.49% | -13.52% | |||
| EPS Diluted | -9.21% | -11.01% | |||
| Normalized Diluted EPS | -11.49% | -13.52% | |||
| Average Basic Shares Outstanding | 2.19% | 0.27% | |||
| Average Diluted Shares Outstanding | 2.19% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 1.00% | 0.56% | |||